NCT02689427 2024-09-19
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
9 trialsNCT00881361 2023-04-27
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT05141630 2021-12-02
Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer
Fudan University
Phase 2 Unknown
NCT02953184 2017-12-29
Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy
Jilin University
Phase 2 Unknown
NCT00575744 2016-10-27
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
University of Arkansas
Phase 2 Completed
NCT02610621 2016-10-13
Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy
Cedars-Sinai Medical Center
Phase 2 Withdrawn
NCT01276054 2014-08-01
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
University of Southern California
Phase 2 Terminated
NCT00005821 2013-11-06
Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00107484 2010-05-03
Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
Virginia Commonwealth University
Phase 2 Completed